Nov 05, 2020
Intec Pharma Reports Third Quarter 2020 Financial Results and Provides Corporate Update
Oct 29, 2020
Intec Pharma Announces 1-for-20 Reverse Share Split
Oct 08, 2020
Intec Pharma Announces New Research Collaboration Agreement with MSD
Sep 14, 2020
Intec Pharma to Present at Oppenheimer Fall Healthcare Life Sciences & MedTech Summit
Sep 08, 2020
Intec Pharma to Present at H.C. Wainwright 22nd Annual Global Investment Conference
Aug 05, 2020
Intec Pharma Reports Second Quarter 2020 Financial Results and Provides Corporate Update
May 28, 2020
Intec Pharma to Present at Jefferies Virtual Healthcare Conference
May 11, 2020
Intec Pharma Reports First Quarter 2020 Financial Results and Provides Corporate Update
Feb 25, 2020
Intec Pharma to Participate at Three Investment Conferences in March
Jan 30, 2020
Intec Pharma Announces Proposed Public Offering
Jan 09, 2020
Intec Pharma Issues Letter to Shareholders
Dec 11, 2019
Intec Pharma Provides Update on Novartis Feasibility and Option Agreement
Dec 06, 2019
Intec Pharma to Present at LD Micro's 12th Annual Main Event
Dec 03, 2019
Intec Pharma Announces $10 Million Ordinary Shares Purchase Agreement With Aspire Capital
Nov 13, 2019
Intec Pharma to Participate in Jefferies London Healthcare Conference
Nov 12, 2019
Intec Pharma Reports Third Quarter 2019 Financial Results and Provides Business Update
Sep 25, 2019
Intec Pharma Highlights Potential of Accordion Pill® Oral Drug Delivery Platform in Two Posters at International Congress of Parkinson's and Movement Disorder Society
Sep 16, 2019
Intec Pharma to Present Two Posters at International Congress of Parkinson's and Movement Disorder Society
Sep 03, 2019
Intec Pharma to Participate in September Investment Conferences
Aug 09, 2019
Intec Pharma Reports Second Quarter 2019 Financial Results and Business Update